# Biosplice

**Canonical:** https://apis.io/providers/biosplice/  
**Website:** https://biosplice.com/  
**APIs profiled:** 0

Biosplice Therapeutics, Inc. is a biopharmaceutical company focused on developing disease-modifying therapies for osteoarthritis. Their lead investigational drug candidate, lorecivivint, aims to halt disease progression and improve joint function. The company provides extensive information about its programs, leadership, and scientific publications through its corporate website, offering resources for patients, researchers, and potential partners.

## Kin Score — 8.8 / 100 (minimal)

Scored 2026-10-04 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 48.2 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.9 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Biosplice Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biopharma, Osteoarthritis, Therapeutics, Clinical Trials

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/biosplice/). Scores are computed from the provider's own public artifacts under a published rubric.